SlideShare a Scribd company logo
From Research to Public Service
What do scientists and engineers do at the TGA
Dr Lee Walsh
Senior Engineer
Biomaterials Engineering, Laboratories Branch
Therapeutic Goods Administration
19/08/2016
Who is the TGA?
• The Therapeutic Goods Administration was
established in 1990 to “safeguard and
enhance the health of the Australian
community through effective and timely
regulation of therapeutic goods”
• It provides a national system of
controls relating to the quality,
safety, efficacy and timely
availability of therapeutic goods
used in, or exported from, Australia
Health
Safety
Regulation
From Research to Public Service 1
Who is the TGA?
• We are part of the Australian Government
Department of Health
• Every decision the TGA makes is based
on the Therapeutic Goods Act 1989
• Main offices in Canberra – satellite
offices in Sydney, Melbourne, Adelaide
and Brisbane
• Operations are primarily cost recovered
(98%) industry pays fees for making
applications and annual charges for
products they are responsible for
From Research to Public Service 2
Where is the TGA?
Lizards/snakes
Birds
Kangaroos
From Research to Public Service 3
Where is the TGA?
Purpose built
science and
engineering
building
From Research to Public Service 4
Who works at the TGA?
Approximately 750 staff made up of:
Biomedical
scientists
Engineers Physiotherapists Medical officers
Pharmacists Nurses Toxicologists Lawyers
Nutritionists Dieticians Scientists Administrative staff
From Research to Public Service 5
What Sci/Eng do at the TGA
Lab work
From Research to Public Service 6
What Sci/Eng do at the TGA
Reading and writing
From Research to Public Service 7
What Sci/Eng do at the TGA
Analysis
From Research to Public Service 8
What Sci/Eng do at the TGA
Advise &
collaborate
From Research to Public Service 9
What Sci/Eng do at the TGA
Make recommendations
and decisions
From Research to Public Service 10
My roles at the TGA
Medical devices
Pre-market (device assessor)
• Technical expert
– Assess new devices for safety
and performance
– Make recommendations to
decision makers
– Learn about new devices
– Write expert reports
– Develop internal policy and
systems
– Provide technical expertise
Post-market (laboratories)
• Technical leader
– Design testing programs
– Laboratory testing
– Technical assessments
– Develop methods and standards
– Learn about devices
– Write lab and expert reports
– Develop internal policy and
systems
– Provide technical expertise
From Research to Public Service 11
Advantages of being an APS
• Job security
• Good salary (vs research)
• Excellent working conditions
Advantages of working at the TGA
• High impact work
• The work is technically and professionally challenging
• Variety of work relating to medicines and medical devices
• Work with a variety of experts (technical, medical, legal)
• Technical skills, expertise, and experience are highly valued
From Research to Public Service 12
Where would neuroscientists fit?
Biomedical scientists Engineers Physiotherapists Medical officers
Pharmacists Nurses Toxicologists Lawyers
Nutritionists Dieticians Scientists Administrative staff
From Research to Public Service 13
Where to find positions at the TGA?
• The usual places
• TGA Employment and job vacancies
– https://www.tga.gov.au/employment-job-vacancies
– Navigate from theTGA website footer
• APS Jobs
– http://www.apsjobs.gov.au
– Search under Dept/Agency: Therapeutic Goods Administration
From Research to Public Service 14
From Research to Public Service: What do scientists and engineers do at the TGA

More Related Content

What's hot

Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
TGA Australia
 
Presentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilancePresentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilance
TGA Australia
 
Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)
TGA Australia
 
Presentation: Prescription Medicines Reforms
Presentation: Prescription Medicines ReformsPresentation: Prescription Medicines Reforms
Presentation: Prescription Medicines Reforms
TGA Australia
 
Presentation: Online Clinical Trial Notification (CTN)
Presentation: Online Clinical Trial Notification (CTN)Presentation: Online Clinical Trial Notification (CTN)
Presentation: Online Clinical Trial Notification (CTN)
TGA Australia
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
TGA Australia
 
Presentation: Spotlight on complementary medicines MMDR reforms
Presentation: Spotlight on complementary medicines MMDR reformsPresentation: Spotlight on complementary medicines MMDR reforms
Presentation: Spotlight on complementary medicines MMDR reforms
TGA Australia
 
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...
TGA Australia
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
TGA Australia
 
Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...
TGA Australia
 
Presentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reformsPresentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reforms
TGA Australia
 
TGA presentation: Provisional approval pathway for prescription medicines
TGA presentation: Provisional approval pathway for prescription medicinesTGA presentation: Provisional approval pathway for prescription medicines
TGA presentation: Provisional approval pathway for prescription medicines
TGA Australia
 
Presentation: Conformity assessment evidence
Presentation: Conformity assessment evidencePresentation: Conformity assessment evidence
Presentation: Conformity assessment evidence
TGA Australia
 
Presentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramPresentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection Program
TGA Australia
 
Presentation: Pharmacovigilance: The Australian landscape
Presentation: Pharmacovigilance: The Australian landscapePresentation: Pharmacovigilance: The Australian landscape
Presentation: Pharmacovigilance: The Australian landscape
TGA Australia
 
Gmp slide deck for slide share v3 for explainer video
Gmp slide deck for slide share v3 for explainer videoGmp slide deck for slide share v3 for explainer video
Gmp slide deck for slide share v3 for explainer video
James G. Schleck
 
Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...
TGA Australia
 
Presentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionPresentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflection
TGA Australia
 
Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)
TGA Australia
 
TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017 TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017
TGA Australia
 

What's hot (20)

Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
Presentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilancePresentation: The role of the patient in pharmacovigilance
Presentation: The role of the patient in pharmacovigilance
 
Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)
 
Presentation: Prescription Medicines Reforms
Presentation: Prescription Medicines ReformsPresentation: Prescription Medicines Reforms
Presentation: Prescription Medicines Reforms
 
Presentation: Online Clinical Trial Notification (CTN)
Presentation: Online Clinical Trial Notification (CTN)Presentation: Online Clinical Trial Notification (CTN)
Presentation: Online Clinical Trial Notification (CTN)
 
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
The TGA Pharmacovigilance Inspection Pilot Program: 2015-2016
 
Presentation: Spotlight on complementary medicines MMDR reforms
Presentation: Spotlight on complementary medicines MMDR reformsPresentation: Spotlight on complementary medicines MMDR reforms
Presentation: Spotlight on complementary medicines MMDR reforms
 
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...
TGA presentation: MMDR Consultation - Strengthening monitoring of medicines i...
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
 
Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...Expert review of medicines and medical devices regulation: Prescription medic...
Expert review of medicines and medical devices regulation: Prescription medic...
 
Presentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reformsPresentation: Spotlight on prescription medicines reforms
Presentation: Spotlight on prescription medicines reforms
 
TGA presentation: Provisional approval pathway for prescription medicines
TGA presentation: Provisional approval pathway for prescription medicinesTGA presentation: Provisional approval pathway for prescription medicines
TGA presentation: Provisional approval pathway for prescription medicines
 
Presentation: Conformity assessment evidence
Presentation: Conformity assessment evidencePresentation: Conformity assessment evidence
Presentation: Conformity assessment evidence
 
Presentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection ProgramPresentation: The Australian Pharmacovigilance Inspection Program
Presentation: The Australian Pharmacovigilance Inspection Program
 
Presentation: Pharmacovigilance: The Australian landscape
Presentation: Pharmacovigilance: The Australian landscapePresentation: Pharmacovigilance: The Australian landscape
Presentation: Pharmacovigilance: The Australian landscape
 
Gmp slide deck for slide share v3 for explainer video
Gmp slide deck for slide share v3 for explainer videoGmp slide deck for slide share v3 for explainer video
Gmp slide deck for slide share v3 for explainer video
 
Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...Presentation: A spotlight on other reforms from the medicines and medical dev...
Presentation: A spotlight on other reforms from the medicines and medical dev...
 
Presentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflectionPresentation: What's trending in medicines regulation? A January 2017 reflection
Presentation: What's trending in medicines regulation? A January 2017 reflection
 
Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)
 
TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017 TGA presentation: AusMedtech, 24 May 2017
TGA presentation: AusMedtech, 24 May 2017
 

Viewers also liked

Risk-based approach to infectious disease safety
Risk-based approach to infectious disease safetyRisk-based approach to infectious disease safety
Risk-based approach to infectious disease safety
TGA Australia
 
VirComm13JohnCoateKeynote
VirComm13JohnCoateKeynoteVirComm13JohnCoateKeynote
VirComm13JohnCoateKeynoteRebecca Newton
 
Presentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesPresentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissues
TGA Australia
 
Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016
TGA Australia
 
Updating medicine ingredient names: International harmonisation of ingredient...
Updating medicine ingredient names: International harmonisation of ingredient...Updating medicine ingredient names: International harmonisation of ingredient...
Updating medicine ingredient names: International harmonisation of ingredient...
TGA Australia
 
Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)
TGA Australia
 
Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...
Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...
Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...
TGA Australia
 
Presentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesPresentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissues
TGA Australia
 
What’s in a name - biosimilars?
What’s in a name - biosimilars?What’s in a name - biosimilars?
What’s in a name - biosimilars?
TGA Australia
 
Complementary medicines MMDR reforms: Assessment pathways
Complementary medicines MMDR reforms: Assessment pathwaysComplementary medicines MMDR reforms: Assessment pathways
Complementary medicines MMDR reforms: Assessment pathways
TGA Australia
 

Viewers also liked (10)

Risk-based approach to infectious disease safety
Risk-based approach to infectious disease safetyRisk-based approach to infectious disease safety
Risk-based approach to infectious disease safety
 
VirComm13JohnCoateKeynote
VirComm13JohnCoateKeynoteVirComm13JohnCoateKeynote
VirComm13JohnCoateKeynote
 
Presentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesPresentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissues
 
Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016
 
Updating medicine ingredient names: International harmonisation of ingredient...
Updating medicine ingredient names: International harmonisation of ingredient...Updating medicine ingredient names: International harmonisation of ingredient...
Updating medicine ingredient names: International harmonisation of ingredient...
 
Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)
 
Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...
Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...
Presentation: Revision of the Uniform Recall Procedure for Therapeutic Goods ...
 
Presentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissuesPresentation: Regulation of autologous cells and tissues
Presentation: Regulation of autologous cells and tissues
 
What’s in a name - biosimilars?
What’s in a name - biosimilars?What’s in a name - biosimilars?
What’s in a name - biosimilars?
 
Complementary medicines MMDR reforms: Assessment pathways
Complementary medicines MMDR reforms: Assessment pathwaysComplementary medicines MMDR reforms: Assessment pathways
Complementary medicines MMDR reforms: Assessment pathways
 

Similar to From Research to Public Service: What do scientists and engineers do at the TGA

Zicom_MedTacc
Zicom_MedTaccZicom_MedTacc
Zicom_MedTaccEmril Ali
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updates
TGA Australia
 
OneStart 2013 Finalists (Europe)
OneStart 2013 Finalists (Europe)OneStart 2013 Finalists (Europe)
OneStart 2013 Finalists (Europe)
Oxbridge Biotech Roundtable
 
IP and Innovation Presentation Lang v2
IP and Innovation Presentation Lang v2IP and Innovation Presentation Lang v2
IP and Innovation Presentation Lang v2Dr. Thach Lang
 
TGA presentation: The role of the TGA
TGA presentation: The role of the TGATGA presentation: The role of the TGA
TGA presentation: The role of the TGA
TGA Australia
 
Food Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry PresentationFood Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry Presentation
wzawhat
 
P-173 CTL new spex added 100516
P-173 CTL new spex added 100516P-173 CTL new spex added 100516
P-173 CTL new spex added 100516Kiran Bains
 
Discovering New Innovations in Oncology
Discovering New Innovations in OncologyDiscovering New Innovations in Oncology
Discovering New Innovations in Oncology
InsideScientific
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdfSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
ArshaqKN
 
ICH-E2A: Safety Reporting in Clinical Trials in Australia
ICH-E2A: Safety Reporting in Clinical Trials in AustraliaICH-E2A: Safety Reporting in Clinical Trials in Australia
ICH-E2A: Safety Reporting in Clinical Trials in Australia
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
OneStart Top 10 Finalists
OneStart Top 10 FinalistsOneStart Top 10 Finalists
OneStart Top 10 Finalistsjohndaley89
 
One start finalists
One start finalistsOne start finalists
One start finalistsjohndaley89
 
Presentation: Navigating regulation
Presentation: Navigating regulation Presentation: Navigating regulation
Presentation: Navigating regulation
TGA Australia
 
Regulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studiesRegulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studies
UBMCanon
 
An introduction to the work of Australia's regulator of therapeutic goods
An introduction to the work of Australia's regulator of therapeutic goodsAn introduction to the work of Australia's regulator of therapeutic goods
An introduction to the work of Australia's regulator of therapeutic goods
TGA Australia
 
Research and Development Solutions | Accenture
Research and Development Solutions | AccentureResearch and Development Solutions | Accenture
Research and Development Solutions | Accenture
accenture
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptxSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
KapoorSonam
 
TetraQ Services Presentation
TetraQ Services PresentationTetraQ Services Presentation
TetraQ Services Presentationsimonsend
 
E&L workshop Session 1 for the identificationdf
E&L workshop Session 1 for the identificationdfE&L workshop Session 1 for the identificationdf
E&L workshop Session 1 for the identificationdf
ThippaniRameshVarma
 
LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016Yan Zhi
 

Similar to From Research to Public Service: What do scientists and engineers do at the TGA (20)

Zicom_MedTacc
Zicom_MedTaccZicom_MedTacc
Zicom_MedTacc
 
TGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updatesTGA Presentation: Biologicals framework updates
TGA Presentation: Biologicals framework updates
 
OneStart 2013 Finalists (Europe)
OneStart 2013 Finalists (Europe)OneStart 2013 Finalists (Europe)
OneStart 2013 Finalists (Europe)
 
IP and Innovation Presentation Lang v2
IP and Innovation Presentation Lang v2IP and Innovation Presentation Lang v2
IP and Innovation Presentation Lang v2
 
TGA presentation: The role of the TGA
TGA presentation: The role of the TGATGA presentation: The role of the TGA
TGA presentation: The role of the TGA
 
Food Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry PresentationFood Nutraceutical Packaging Chemistry Presentation
Food Nutraceutical Packaging Chemistry Presentation
 
P-173 CTL new spex added 100516
P-173 CTL new spex added 100516P-173 CTL new spex added 100516
P-173 CTL new spex added 100516
 
Discovering New Innovations in Oncology
Discovering New Innovations in OncologyDiscovering New Innovations in Oncology
Discovering New Innovations in Oncology
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdfSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pdf
 
ICH-E2A: Safety Reporting in Clinical Trials in Australia
ICH-E2A: Safety Reporting in Clinical Trials in AustraliaICH-E2A: Safety Reporting in Clinical Trials in Australia
ICH-E2A: Safety Reporting in Clinical Trials in Australia
 
OneStart Top 10 Finalists
OneStart Top 10 FinalistsOneStart Top 10 Finalists
OneStart Top 10 Finalists
 
One start finalists
One start finalistsOne start finalists
One start finalists
 
Presentation: Navigating regulation
Presentation: Navigating regulation Presentation: Navigating regulation
Presentation: Navigating regulation
 
Regulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studiesRegulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studies
 
An introduction to the work of Australia's regulator of therapeutic goods
An introduction to the work of Australia's regulator of therapeutic goodsAn introduction to the work of Australia's regulator of therapeutic goods
An introduction to the work of Australia's regulator of therapeutic goods
 
Research and Development Solutions | Accenture
Research and Development Solutions | AccentureResearch and Development Solutions | Accenture
Research and Development Solutions | Accenture
 
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptxSession_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
Session_3_Meet_Some_of_the_Most_Innovative_Hospitals.pptx
 
TetraQ Services Presentation
TetraQ Services PresentationTetraQ Services Presentation
TetraQ Services Presentation
 
E&L workshop Session 1 for the identificationdf
E&L workshop Session 1 for the identificationdfE&L workshop Session 1 for the identificationdf
E&L workshop Session 1 for the identificationdf
 
LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016LTD introduction slides - Jan. 2016
LTD introduction slides - Jan. 2016
 

More from TGA Australia

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
TGA Australia
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
TGA Australia
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
TGA Australia
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
TGA Australia
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
TGA Australia
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
TGA Australia
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
TGA Australia
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
TGA Australia
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
TGA Australia
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
TGA Australia
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Australia
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Australia
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
TGA Australia
 

More from TGA Australia (20)

Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
The challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devicesThe challenges of regulating direct to consumer digital medical devices
The challenges of regulating direct to consumer digital medical devices
 
Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch Updates from the Pharmacovigilance and Special Access Branch
Updates from the Pharmacovigilance and Special Access Branch
 
Consumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI templateConsumer Medicine Information - Improving the CMI template
Consumer Medicine Information - Improving the CMI template
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
Improved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future stateImproved electronic submission methodologies - Challenges and future state
Improved electronic submission methodologies - Challenges and future state
 
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...Regulation, ethics and reimbursement of novel biological therapies in Austral...
Regulation, ethics and reimbursement of novel biological therapies in Austral...
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation BranchUpdate on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2Regulatory updates from the TGA Medical Devices Branch - Part 2
Regulatory updates from the TGA Medical Devices Branch - Part 2
 
SME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory mazeSME Assist: Help to navigate the regulatory maze
SME Assist: Help to navigate the regulatory maze
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access BranchPresentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: Updates from the Pharmacovigilance and Special Access Branch
 
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: The challenges of regulating direct to consumer digital medical...
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...Webinar presentation: Consultation on reforms to the generic medicine market ...
Webinar presentation: Consultation on reforms to the generic medicine market ...
 

Recently uploaded

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Antimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistanceAntimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistance
GovindRankawat1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
NEHA GUPTA
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 

Recently uploaded (20)

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Antimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistanceAntimicrobial stewardship to prevent antimicrobial resistance
Antimicrobial stewardship to prevent antimicrobial resistance
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 

From Research to Public Service: What do scientists and engineers do at the TGA

  • 1. From Research to Public Service What do scientists and engineers do at the TGA Dr Lee Walsh Senior Engineer Biomaterials Engineering, Laboratories Branch Therapeutic Goods Administration 19/08/2016
  • 2. Who is the TGA? • The Therapeutic Goods Administration was established in 1990 to “safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods” • It provides a national system of controls relating to the quality, safety, efficacy and timely availability of therapeutic goods used in, or exported from, Australia Health Safety Regulation From Research to Public Service 1
  • 3. Who is the TGA? • We are part of the Australian Government Department of Health • Every decision the TGA makes is based on the Therapeutic Goods Act 1989 • Main offices in Canberra – satellite offices in Sydney, Melbourne, Adelaide and Brisbane • Operations are primarily cost recovered (98%) industry pays fees for making applications and annual charges for products they are responsible for From Research to Public Service 2
  • 4. Where is the TGA? Lizards/snakes Birds Kangaroos From Research to Public Service 3
  • 5. Where is the TGA? Purpose built science and engineering building From Research to Public Service 4
  • 6. Who works at the TGA? Approximately 750 staff made up of: Biomedical scientists Engineers Physiotherapists Medical officers Pharmacists Nurses Toxicologists Lawyers Nutritionists Dieticians Scientists Administrative staff From Research to Public Service 5
  • 7. What Sci/Eng do at the TGA Lab work From Research to Public Service 6
  • 8. What Sci/Eng do at the TGA Reading and writing From Research to Public Service 7
  • 9. What Sci/Eng do at the TGA Analysis From Research to Public Service 8
  • 10. What Sci/Eng do at the TGA Advise & collaborate From Research to Public Service 9
  • 11. What Sci/Eng do at the TGA Make recommendations and decisions From Research to Public Service 10
  • 12. My roles at the TGA Medical devices Pre-market (device assessor) • Technical expert – Assess new devices for safety and performance – Make recommendations to decision makers – Learn about new devices – Write expert reports – Develop internal policy and systems – Provide technical expertise Post-market (laboratories) • Technical leader – Design testing programs – Laboratory testing – Technical assessments – Develop methods and standards – Learn about devices – Write lab and expert reports – Develop internal policy and systems – Provide technical expertise From Research to Public Service 11
  • 13. Advantages of being an APS • Job security • Good salary (vs research) • Excellent working conditions Advantages of working at the TGA • High impact work • The work is technically and professionally challenging • Variety of work relating to medicines and medical devices • Work with a variety of experts (technical, medical, legal) • Technical skills, expertise, and experience are highly valued From Research to Public Service 12
  • 14. Where would neuroscientists fit? Biomedical scientists Engineers Physiotherapists Medical officers Pharmacists Nurses Toxicologists Lawyers Nutritionists Dieticians Scientists Administrative staff From Research to Public Service 13
  • 15. Where to find positions at the TGA? • The usual places • TGA Employment and job vacancies – https://www.tga.gov.au/employment-job-vacancies – Navigate from theTGA website footer • APS Jobs – http://www.apsjobs.gov.au – Search under Dept/Agency: Therapeutic Goods Administration From Research to Public Service 14